{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:01:07Z","timestamp":1749355267118,"version":"3.41.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.2169\/internalmedicine.4366-24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:11:53Z","timestamp":1729203113000},"page":"1746-1749","source":"Crossref","is-referenced-by-count":0,"title":["KL-6 as a Tumor Marker of Primary Peritoneal Cancer in Patients with Connective Tissue Diseases"],"prefix":"10.2169","volume":"64","author":[{"given":"Takao","family":"Nagashima","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"},{"name":"Division of Rheumatology, First Department of Integrated Medicine, Jichi Medical University Saitama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"unstructured":"1. Kohno N. Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 46: 151-158, 1999.","key":"1"},{"doi-asserted-by":"crossref","unstructured":"2. Kuwana M, Shirai Y, Takeuchi T. Elevated serum Krebs von den Lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease. J Rheumatol 43: 1825-1831, 2016.","key":"2","DOI":"10.3899\/jrheum.160339"},{"doi-asserted-by":"crossref","unstructured":"3. Benyamine A, Heim X, Resseguier N, et al. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Rheumatol Int 38: 813-819, 2018.","key":"3","DOI":"10.1007\/s00296-018-3987-3"},{"doi-asserted-by":"crossref","unstructured":"4. Yamaguchi K, Iwamoto H, Sakamoto S, et al. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: a retrospective cohort study. Medicine (Baltimore) 97: e13542, 2018.","key":"4","DOI":"10.1097\/MD.0000000000013542"},{"unstructured":"5. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18: 203-216, 1988.","key":"5"},{"doi-asserted-by":"crossref","unstructured":"6. Yanagisawa N, Koide N, Fukai H, Koyama Y, Ogihara Y, Ohya M. Two cases of gastric cancer with elevated serum levels of KL-6. Surg Case Rep 10: 82, 2024.","key":"6","DOI":"10.1186\/s40792-024-01883-0"},{"unstructured":"7. Maeda M, Iwami S, Matsuoka H, Suizu A, Murakami H, Fujii T. A case of dermatomyositis with peritoneal cancer diagnosed by thoracoscopic and laparoscopic biopsy. Sanfujinka no Shinpo (Adv Obstet Gynecol) 73: 238-246, 2021 (in Japanese).","key":"7"},{"doi-asserted-by":"crossref","unstructured":"8. Gan J, Herzog J, Smith DA, et al. Primary peritoneal serous carcinoma: a primer for radiologists. Clin Imaging 83: 56-64, 2022.","key":"8","DOI":"10.1016\/j.clinimag.2021.12.007"},{"doi-asserted-by":"crossref","unstructured":"9. Sorensen RD, Schnack TH, Karlsen MA, Hogdall CK. Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review. Gynecol Oncol 136: 571-581, 2015.","key":"9","DOI":"10.1016\/j.ygyno.2015.01.534"},{"doi-asserted-by":"crossref","unstructured":"10. Sato S, Kato T, Abe K, et al. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncol Lett 14: 776-786, 2017.","key":"10","DOI":"10.3892\/ol.2017.6254"},{"unstructured":"11. Fukuhara N, Tanino Y, Sato S, et al. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 32: 265-270, 2015.","key":"11"},{"doi-asserted-by":"crossref","unstructured":"12. Yonenaga Y, Kurosawa M, Higashide S. Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report. Int Cancer Conf J 10: 119-126, 2021.","key":"12","DOI":"10.1007\/s13691-020-00460-0"},{"doi-asserted-by":"crossref","unstructured":"13. Kawata T, Tsukagoshi H, Mashimo T, et al. KL-6-producing invasive thymoma. Intern Med 41: 979-982, 2002.","key":"13","DOI":"10.2169\/internalmedicine.41.979"},{"doi-asserted-by":"crossref","unstructured":"14. Kida Y, Maeshima E, Furukawa K, Ichikawa T, Goda M, Ichinose M. A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol 17: 262-264, 2007.","key":"14","DOI":"10.1007\/s10165-007-0579-6"},{"doi-asserted-by":"crossref","unstructured":"15. Gyorfi AH, Filla T, Dickel N, et al. Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford) 63: 962-969, 2024.","key":"15","DOI":"10.1093\/rheumatology\/kead332"},{"doi-asserted-by":"crossref","unstructured":"16. Mangogna A, Belmonte B, Agostinis C, et al. Pathological significance and prognostic value of surfactant protein D in cancer. Front Immunol 9: 1748, 2018.","key":"16","DOI":"10.3389\/fimmu.2018.01748"},{"doi-asserted-by":"crossref","unstructured":"17. Gad A, Tanaka E, Matsumoto A, et al. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. World J Gastroenterol 11: 6607-6612, 2005.","key":"17","DOI":"10.3748\/wjg.v11.i42.6607"},{"unstructured":"18. Ogawa Y, Ishikawa T, Ikeda K, et al. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 6: 4069-4072, 2000.","key":"18"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4366-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:38:47Z","timestamp":1749271127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4366-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4366-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"4366-24"}}